Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Palomo

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Genes, Chromosomes & Cancer|October 18, 2016
Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemiaAnna Palau, Mar Mallo, Laura Palomo, et al.
Biopreservation and Biobanking|June 7, 2017
Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome PatientsLaura Palomo, Francisco Fuster-Tormo, Daniel Alvira, et al.
Cancers|March 6, 2021
Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell ApproachPamela Acha, Laura Palomo, Francisco Fuster-Tormo, et al.
Epigenetics|November 22, 2017
DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic featuresLaura Palomo, Roberto Malinverni, Marta Cabezón, et al.
Journal of Proteomics|April 22, 2014
Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicityEva Rodríguez-Suárez, Esperanza Gonzalez, Chris Hughes, et al.
Genes|January 16, 2020
Bone Marrow Clonogenic Myeloid Progenitors from <i>NPM1</i>-Mutated AML Patients Do Not Harbor the <i>NPM1</i> Mutation: Implication for the Cell-Of-Origin of <i>NPM1+</i> AMLRafael Diaz de la Guardia, Laura González-Silva, Belén López-Millán, et al.
Scientific Reports|September 19, 2018
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMMLAntònia Banús-Mulet, Amaia Etxabe, Josep Maria Cornet-Masana, et al.
Journal of Clinical Medicine|October 27, 2022
Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia PatientsNatalia Estrada, Lurdes Zamora, Francisca Ferrer-Marín, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
Oncotarget|May 4, 2018
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidineMarta Cabezón, Joan Bargay, Blanca Xicoy, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Genes, Chromosomes & Cancer|October 18, 2016
Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemiaAnna Palau, Mar Mallo, Laura Palomo, et al.
Biopreservation and Biobanking|June 7, 2017
Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome PatientsLaura Palomo, Francisco Fuster-Tormo, Daniel Alvira, et al.
Cancers|March 6, 2021
Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell ApproachPamela Acha, Laura Palomo, Francisco Fuster-Tormo, et al.
Epigenetics|November 22, 2017
DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic featuresLaura Palomo, Roberto Malinverni, Marta Cabezón, et al.
Journal of Proteomics|April 22, 2014
Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicityEva Rodríguez-Suárez, Esperanza Gonzalez, Chris Hughes, et al.
Genes|January 16, 2020
Bone Marrow Clonogenic Myeloid Progenitors from <i>NPM1</i>-Mutated AML Patients Do Not Harbor the <i>NPM1</i> Mutation: Implication for the Cell-Of-Origin of <i>NPM1+</i> AMLRafael Diaz de la Guardia, Laura González-Silva, Belén López-Millán, et al.
Scientific Reports|September 19, 2018
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMMLAntònia Banús-Mulet, Amaia Etxabe, Josep Maria Cornet-Masana, et al.
Journal of Clinical Medicine|October 27, 2022
Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia PatientsNatalia Estrada, Lurdes Zamora, Francisca Ferrer-Marín, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
Oncotarget|May 4, 2018
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidineMarta Cabezón, Joan Bargay, Blanca Xicoy, et al.
Pageof 5